Osseointegration has been defined as the direct structural and functional connection between ordered, living bone and the surface of a load-carrying implant. To date, this concept has been described by descriptive histological and ultrastructural criteria but not by biochemical means. This review evaluates the basic science work performed on this concept and then applies the concept to the principle of osseous healing. Specific studies are cited where alterations in the healing response are due to clinical management of implant placement and how studies of surface properties may lead to further insights on implant design and prognosis. In addition, a review of bone expression as a function of in vitro stress applications is given. This is followed by an in-depth review of the collagens and noncollagenous proteins, described to date, within isolated bone matrix. It is this collagenous matrix (especially type I) that is described as being close to and oriented with a glycoprotein component next to the implant surface. In turn, the large family of noncollagenous proteins are important in mediating bone proliferation, matrix accumulation, orientation, mineralization, and turnover. This section is followed by a discussion of specific growth factors as they may relate to osseous healing around an implant.
References
1.
Brånemark, P.I., Osseointegration and its experimental background, J. Pros. Dent., 50, 399, 1983.
2.
Adell, R., Lekholm, U., Rockier, B., and Branemark, P.I., A 15-year study of osseointegrated implants in the treatment of the edentulous jaw, Int. J. Oral Surg., 10, 387, 1981.
3.
Adell, R., Clinical results of osseointegrated implants supporting fixed prostheses in edentulous jaws, J. Pros. Dent., 50, 251, 1983.
4.
Branemark, P.I., Introduction to Osseointegration, in Tissue Integrated Prostheses, Branemark, P. I. and Albrektsson, T., Eds., Quintessence, Chicago, 1985, chap. 1.
5.
Hicks, J.H., Pathological effects from surgical metal, in Modern Trends in Surgical Materials, Gillis, L., Ed., Butterworth & Company, London, 29.
6.
Linder, L., Albrektsson, T., Branemark, P.I., Hansson, H.-A., Ivarsson, B., Jonsson, U., and Lundstrom, I., Electron microscopic analysis of the bone-titanium interface, Acta Orthop. Scand., 54, 45, 1983.
7.
Clavin, T.J., Keller, J.C., Wick, D.G., and Stanford, C.M., Development of a model for cell attachment, J. Dent. Res., 69, 369, 1990.
8.
Michaels, C.M., Keller, J.C., Stanford, C.M., and Rittman, G.A., In vitro PDL fibroblast attachment to plasma cleaned Ti surfaces, J. Dent. Res., 69, 369, 1990.
9.
Stanford, C.M., Keller, J.C., Wick, D.G., and Solursh, M., Protein adsorption is decreased on glow discharged treated cpTi, J. Dent. Res., 2088, 369, 1990.
10.
Keller, J.C., Draughn, R.A., and Wightman, J.P., Characterization of plasma cleaned cpTi surfaces, J. Dent. Res., 69, 369, 1990.
11.
Bowers, K.T., Keller, J.C., Wick, D.G., and Randolph, B.A., Optimization of surface morphology for osteoblast attachment, J. Dent. Res., 2091, 369, 1990.
12.
Werb, A., Tremble, P.M., Behrendtsen, O., Crowley, E., and Damsky, C.H., Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression, J. Cell Biol., 109, 877, 1989.
13.
Albrektsson, T., Zarb, G., Worthington, P., and Eriksson, A.R., The long-term efficacy of currently used dental implants: a review and proposed criteria of success, Int. J. Oral Maxillofac. Implants, 1,11. 1986.
14.
Young, F.A. and Keller, J.C., Porous titanium dental implants in primates and humans, Mech. Eng., C215, 9, 1984.
15.
Keller, J.C., Young, F.A., and Natiella, J.R., Quantitative bone remodeling resulting from the use of porous dental implants, J. Biomed. Mater. Res., 21, 305, 1987.
16.
Keller, J.C., Young, F.A., and Trancik, T.M., A simplified model for studying bone ingrowth, Int. J. Oral Maxillofac. Implants, 2, 149, 1987.
17.
Keller, J.C. and Young, F.A., Histomorphometric analysis of bone ingrowth into porous-coated dental implants, in ASTM STP 953, Lemmons, J. E., Ed., ASTM, Philadelphia, 1987, 219.
18.
Kasemo, B., Biocompatibility of titanium implants: surface science aspects, J. Pros. Dent., 49, 832, 1983.
19.
Parr, G.R., Titanium: the mystery metal of implant dentistry, J. Pros. Dent., 54, 399, 1983.
20.
Lausmaa, J., Accelerated oxide growth on titanium implants during autoclaving caused by Fl contamination, Biomaterials, 5, 23, 1985.
21.
Meenaghan, M.A., Tissue response to surface treated tantalum implants, J. Biomed. Mater. Res., 13, 631, 1979.
22.
Baier, R.E., Conditioning surfaces to suit the biomedical environment: recent progress, J. Biomech. Eng., 104, 257, 1982.
23.
Baier, R.E., Natiella, J.R., Mayer, A.E., and Carter, J.M., Importance of implant surface preparation for biomaterials with different intrinsic properties, in Tissue Integration in Oral and Maxillofacial Reconstruction, van Steenberghe, D., Ed., Excerpta Medica, Amsterdam, 1986, 13.
24.
Baumhammer, A., Scanning electron microscopy of contaminated Ti implants following various cleaning techniques, Oral Implantol., 6, 202, 1975.
25.
Young, F.A., Future directions in dental implant materials research, J. Dent. Ed., 52, 770, 1988.
26.
Ham, A.W., A histologic study of the early phases of bone repair, J. Bone Jt. Surg., 12, 827, 1930.
27.
Ham, A.W. and Harris, W.R., Repair and transplantation of bone, in The Biochemistry and Physiology of Bone, Bourne, G. H., Ed., Academic Press, New York, 1971, 337.
28.
Draenert, Y. and Draenert, K., Gap healing of compact bone, Scand. Elect. Micro., 4, 103, 1980.
29.
McKibbin, B., The biology of fracture healing in long bones, J. Bone Jt. Surg., 60, 150, 1978.
30.
Winet, H. and Albrektsson, T., Wound healing in the bone chamber. I. Neoosteogenesis during transition from the repair to the regenerative phase in the rabbit tibial cortex, J. Orthop. Res., 6, 531, 1988.
31.
Tenenbaum, H.C. and Heersche, J.N.M., Differentiation of osteoid-producing cells in vitro: possible evidence for the requirement of a microenvironment, Calif. Tissue Int., 38, 262, 1986.
32.
Streuli, C.H. and Bissell, M.J., Expression of extracellular matrix components is regulated by substratum, J. Cell Biol., 110, 1405, 1990.
33.
Hansson, H.-A., Albrektsson, T., and Branemark, P.I., Structural aspects of the interface between tissue and titanium implants, J. Pros. Dent., 50, 108, 1983.
34.
McQueen, D., Sundgren, B., Ivarsson, I., Lundstrom, B., Svensson, A., Branemark, P.I., and Albrektsson, T., Auger electron spectroscopic studies of titanium implants, in Clinical Applications of Biomaterials, John Wiley & Sons, New York, 1982, 179.
35.
Davies, J.E. and Matsuda, T., Extracellular matrix production by osteoblasts on bioactive substrata in vitro, Scand. Micro., 2, 1445, 1988.
36.
Owen, M., The origin of bone cells in the postnatal organism, Arthritis Rheum., 23, 1073, 1980.
37.
Heinegard, D. and Oldberg, A., Structure and biology of cartilage and bone matrix noncollagenous macromolecules, FASEB J., 3, 2042, 1989.
38.
Canalis, E., McCarthy, T.L., and Centrella, M., The role of growth factors in skeletal remodeling, Endo. Metab. Clinics N. Am., 18, 903, 1989.
39.
Robey, P.G., The biochemistry of bone, Endo. Metab. Clinics N. Am., 18, 859, 1989.
40.
Martin, T.J., Ng, K.W., and Suda, T., Bone cell physiology, Endo. Metab. Clinics N. Am., 18, 833, 1989.
41.
Boyde, A. and Jones, S., Bone modelling in the implantation bed, J. Biomed. Mater. Res., 19, 199, 1985.
42.
Butler, W.T., Matrix macromolecules of bone and dentin, Coll. Rel. Res., 4, 297, 1984.
43.
Marks, S.C. and Popoff, S.N., Bone cell biology: the regulation of develoment, structure, and function in the skeleton, Am. J. Anat., 183, 1, 1988.
44.
Boskey, A., Noncollagenous matrix proteins and their role in mineralization, Bone and Miner., 6, 111, 1989.
Eriksson, A.R. and Albrektsson, T., Temperature threshold levels for heat-induced bone tissue injury: a vital microscopic study in the rabbit, J. Pros. Dent., 50, 101, 1983.
47.
Eriksson, A., Albrektsson, T., Grane, B., and McQueen, D., Thermal injury to bone. A vital microscopic description of heat effects, Int. J. Oral Surg., 11, 151, 1982.
48.
Urist, M.R., Calcification and ossification. III. The role of local transfer of bone salt in the calcification of the fracture callus, J. Bone Jt. Surg., 24, 47, 1942.
49.
Urist, M.R., The healing of bone, Proc. Soc. Exp. Biol. Med., 104, 35, 1960.
50.
Urist, M.R., The healing of bone, Proc. Soc. Exp. Biol. Med., 104, 35, 1960.
51.
Tonna, E.A. and Cronkite, E.P., The cellular response to fracture studied with tritiated thymidine, J. Bone Jt. Surg., 43A, 352, 1961.
52.
Hart, H.H., Wu, J.-J., Chao, E.Y.S., and Kelly, P.J., External skeletal fixation of canine tibial osteotomies, J. Bone Jt. Surg., 67A, 598, 1985.
53.
Deporter, D.A., Watson, P.A., Pillar, R.M., Melcher, A.H., Winslow, J., Howley, T.P., Hansel, P., Maniatopoulos, D., Rodriguez, A., Abdulla, D., Parisian, K., and Smith, D.C., A histological assessment of the initial healing response adjacent to porous-surfaced, titanium alloy dental implants in dogs, J. Dent. Res., 65, 1064, 1986.
54.
Bobyn, J.D., Pillar, R.M., Cameron, H.U., and Weatherly, G.C., The optimum pore size for the fixation of porous-surfaced metal implants by the ingrowth of bone, Clin. Orthop. Rel. Res., 150, 263, 1980.
55.
Ketenjian, A.Y. and Arsenis, C., Morphological and biochemical studies during differentiation and calcification of fracture callus cartilage, Clin. Orthop., 107, 266, 1975.
56.
Reddi, A.H., Implant-stimulated interface reactions during collagenous bone matrix-induced bone formation, J. Biomed. Mater. Res., 19, 233, 1985.
57.
Sampath, T.K. and Reddi, A.H., Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation, Proc. Natl. Acad. Sci. U.S.A., 78, 7599, 1981.
58.
Reddi, A.H., Hascall, V.C., and Hascall, G.K., Changes in proteoglycan types during matrix-induced cartilage and bone development, J. Biol. Chem., 253, 2426, 1978.
59.
Reddi, A.H., Cell biology and biochemistry of endochondral bone development, Coll. Res., 1, 209, 1981.
60.
Reddi, A.H. and Anderson, W.A., Collagenous bone matrix-induced endochondral ossification and hemopoiesis, J. Cell Biol., 69, 557, 1976.
61.
Reddi, A.H., Collagen and cell differentiation, in Biochemistry of Collagen, Ramachandran, G. N. and Reddi, A. H., Eds., Plenum Press, New York, 1976, 449.
62.
Paralkar, V.M., Nandedkar, A.K., and Reddi, A.H., Affinity of osteogenin, an extracellular bone matrix associated protein initiating bone differentiation, for Concanavalin A, Biochem. Biophys. Res. Commun., 160, 419, 1989.
63.
van Der Plas, A. and Mijweide, P.J., Cell-cell interactions in the osteogenic compartment of bone, Bone, 9, 107, 1988.
64.
Carter, D.R., Blenman, P.R., and Beaupre, G.S., Correlations between mechanical stress history and tissue differentiation in initial fracture healing, J. Orthop. Res., 6, 736, 1988.
65.
Ketenjian, A.Y., Jafri, A.M., and Charolampos, A., Studies on the mechanism of callus cartilage differentiation and calcification during fracture healing, Orthop. Clin. N. Am., 9, 43, 1978.
66.
Lane, J.M., Suda, M., van der Mark, K., and Timpl, R., Immunofluorescent localization of structural collagen types in endochondral fracture repair, J. Orthop. Res., 4, 318, 1986.
67.
Simmons, D.J., Fracture healing, in Fundamental and Clinical Bone Physiology, Urist, M. R., Ed., Lippincott, Philadelphia, 1980, 283.
68.
Pauwels, F., Biomechanics of the Locomotor Apparatus, Springer-Verlag, Berlin, 1980.
69.
Klein-Nulend, J., Veldhuizen, J.P., and Burge, E.H., Increased calcification of growth plate cartilage as a result of compressive force, in vitro, Arthritis Rhum., 29, 1002, 1980.
70.
Rodan, G.A., Mensi, T., and Harvey, A.A., Quantitative method for the application of compressive forces to bone in tissue culture, Calcif. Tissue Res., 18, 125, 1975.
71.
Veldhuijzen, J.P., Bourret, L.A., and Rodan, G.A., In vitro studies of the effect of intermittent compressive forces on cartilage cell proliferation, Cell Physiol., 98, 299, 1979.
72.
van Kampen, G.P.J., Veldhuijzen, J.P., Kuijer, R., van de Stadt, R.J., and Schipper, C.A., Cartilage response to mechanical force in high density chondrocyte cultures, Arthritis Rheum., 28,419,1985.
73.
Bagi, C. and Burger, E.H., Mechanical stimulation by intermittent compression stimulates sulfate incorporation and matrix mineralization in fetal mouse long-bone rudiments under serum frees conditions, Calcif. Tissue Int., 45, 342, 1989.
74.
Uchida, A., Yamashita, K., Hashimoto, K., and Shimomura, Y., The effect of mechanical stress on cultured growth cartilage cells, Conn. Tissue Res., 17, 305, 1988.
75.
Somjen, D., Binderman, I., Berger, E., and Harell, A., Bone remodeling induced by physical stress is Prostaglandin E2 mediated, Biochim. Biophys ACTA, 627,91, 1980.
76.
Hasegawa, S., Sato, S., Saito, S., Suzuki, Y., and Brunette, D.M., Mechanical stretching increases the number of cultured bone cells synthesizing and altering their pattern of protein synthesis, Calcif. Tissue Int., 37, 431, 1985.
77.
Buckley, M.J., Banes, A.J., Levin, L.G., Sumpio, B.E., Sato, M., Jordan, R., Gilbert, J., Link, G.W., and Tay, R. T., S., Osteoblasts increase the rate of division and align in response to cyclic, mechanical tension in vitro, Bone Miner., 4, 225, 1988.
78.
Linsenmeyer, T.F., Structure, Molecular Biology and Pathology of Collagen, New York Academy of Science, 1989.
79.
Niyibizi, S. and Eyre, D.R., Identification of the cartilage a 1 (XI) chain in type V collagen from bovine bone, FEBS Lett., 242, 314, 1989.
80.
Pinnell, S.R., Fox, R., and Krane, S.M., Human collagens: differences in glycosylated hydroxylysine in skin and bone, Biochem. Biophys. ACTA, 229, 119, 1971.
81.
Fleischmajer, R.A. and Perlish, J.S., The role of the amino propeptide in collagen fibrillogenesis, Rheumatology, 10, 91, 1986.
82.
Carsson, L., Rostlund, T., Albrektsson, B., and Albrektsson, T., Implant fixation improved by close fit: cylindrical implant-bone interface studied in rabbits, ACTA Orthop. Scand., 59, 272, 1988.
83.
Albrektsson, T., Branemark, P.I., Hansson, H.-A., Ivarsson, B., and Jonsson, U., Ultrastructural analysis of the interface zone of titanium and gold implants, in Clinical Application of Biomaterials, Lee, A. J. C., Ed., John Wiley & Sons, New York, 1982, 167.
84.
Linder, L., Osseointegration of metallic implants. I. Light microscopy in the rabbit, Acta Orthop. Scand., 60, 129, 1989.
85.
Linder, L., Obrant, K., and Bolvin, G., Osseointegration of metallic implants. II. Transmission electron microscopy in the rabbit, Acta Orthop. Scand., 60, 235, 1989.
86.
Davies, J., Lowenberg, B., and Shiga, A., The bone-titanium interface in vitro, in press.
87.
Hauschka, P., Lian, J.B., Cole, D.E.C., and Gundberg, C.M., Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone, Physiol. Rev., 69, 990, 1989.
88.
Price, P.A., Role of vitamin-K dependent proteins in bone metabolism, Annu. Rev. Nutr., 8, 565, 1988.
89.
Hauschka, P.V. and Reid, P.V., Timed appearance of a calcium-binding protein containing gammacarboxyglutamic acid in developing chick bone, Dev. Biol., 65, 426, 1978.
90.
Wians, F.H., Krech, K., and Hauschka, P.V., The effects of magnesium and calcium on osteocalcin adsorption to hydroxyapatite, Magnesium, 2, 83, 1983.
91.
Gerstenfeld, L.C., Chipman, S.D., Glowaki, J., and Lian, J.B., Expression of differentiated function in mineralizing cultures of chicken osteoblasts, Dev. Biol., 122, 49, 1987.
92.
Beresford, J.N., Gallagher, J.A., Poser, J.W., and Russell, R.G.G., Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids, Metab. Bone Dis. Relat. Res., 5, 229, 1984.
93.
Celeste, A.J., Rosen, V., Buecker, R., Kriz, R., Wang, E.A., and Wozney, J.M., Isolation of the human gene for bone Gla protein utilizing mouse and rat cDNA clones, EMBO J., 5, 1885, 1986.
94.
Poser, J.W., Esch, F.S., Ling, N.C., and Price, P.A., Isolation and sequence of the vitamin K-dependent protein from human bone: undercarboxylation of the first glutamic acid residue, J. Biol. Chem., 255, 8685, 1980.
95.
Hauschka, P.V. and Wians, F.H., Osteocalcin-hydroxyapatite interaction in the extracellular organic matrix of bone, Anat. Rec., 224, 180, 1989.
96.
Hauschka, P. and Carr, S.A., Calcium-dependent alpha-helical structure in osteocalcin, Biochemistry, 21, 2538, 1982.
97.
Camarda, A.J., Butler, W.T., and Finkelman, R.D., Immunocytochemical localization of gamma-carboxyglutamic acid-containing proteins and osteocalcin in rat bone and dentin, Calcif. Tissue Int., 40, 349, 1987.
98.
Bronckers, A.L.J.J., Gay, S., and Finkelman, R.D., Developmental appearance of Gla proteins (osteocalcin) and alkaline phosphatase in tooth germs and bone of the rat, Bone Miner., 2, 361, 1987.
99.
Bronckers, A.L.J.J., Gay, S., and DiMuzio, M.T., Immunolocalization of Gamma-carboxyglutamic acid containing proteins in developing rat bones, Coll. Relat. Res., 5, 273, 1985.
100.
Fraser, J.D. and Price, P.A., Lung, heart, and kidney express high levels of mRNA for the vitamin K-dependent matrix Gla protein: implications for the possible functions of matrix Gla protein and for the tissue distribution of the gamma-carboxylase, J. Biol. Chem., 263, 11033, 1988.
101.
Glowacki, J. and Lian, J.B., Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-depleted bone implants, Cell Diff., 21, 247, 1987.
102.
Lian, J.B., Tassinari, M., and Glowaki, J., Resorption of implanted bone prepared from normal and warfarin-treated rats, J. Clin. Invest., 73, 1223, 1984.
103.
Lian, J.B., Dunn, K., and Key, L.L., In vitro degradation of bone particles by human monocytes is decreased with the depletion of the vitamin K-dependent bone protein from matrix, Endocrinology, 118, 1636, 1986.
104.
Einhorn, T.A., Gundberg, C.M., Devlin, V.J., and Warman, J., Fracture healing and Osteocalcin metabolism in vitamin K deficiency, Clin. Orthop., 237, 219, 1988.
105.
Malone, J.D., Teitelbaum, S.L., Griffin, G.L., Senior, R.M., and Kahn, A.J., Recruitment of osteoclast precursors by purified bone matrix constituents, J. Cell Biol., 92, 227, 1982.
106.
Lucas, P.A. and Caplan, A.I., Chemotactic response of embryonic mesenchyme cells, fibroblasts and limb bud mesenchyme cells and muscle derived fibroblasts to TGF-β, Conn. Tiss. Res., 18, 1, 1988.
107.
Lucas, P.A., Price, P.A., and Caplan, A.I., Chemotactic response of mesenchyme cells, fibroblasts and osteoblast-like cells to bone Gla protein, Bone, 9, 319, 1988.
108.
Mundy, G.R. and Poser, J.W., Chemotactic activity of the gamma-carboxyglutamic acid containing protein from bone, Calcif. Tissue Int., 35, 164, 1983.
109.
Price, P.A., Williamson, M.K., and Haba, T., Excessive mineralization with growth plate closure in rats on chronic warfarin treatment, Proc. Natl. Acad. Sci. U.S.A., 79, 7734, 1982.
110.
Romberg, R.W., Werness, P.G., and Riggs, B.L., Inhibition of Hydroxyapatite crystal growth by bone-specific and other calcium binding proteins, Biochemistry, 25, 1176, 1986.
111.
Gendreau, M.A., Krishnaswamy, S., and Mann, K.G., The interaction of bone Gla protein (osteocalcin) with phospholipid vesicles, J. Biol. Chem., 264, 6972, 1989.
112.
Oldberg, A., Franzen, A., and Heinegard, D., Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence, Proc. Natl. Acad. Sci. U.S.A., 83, 8819, 1986.
113.
Somerman, M.J., Prince, C.W., Sauk, J.J., Foster, R.A., and Butler, W.T., Mechanism of fibroblast attachment to bone extracellular matrix: role of a 44 kilodalton bone phosphoprotein, J. Bone Min. Res., 2, 259, 1987.
114.
Somerman, M.J., Fisher, L.W., Foster, R.A., and Sauk, J.J., Human bone sialoprotein I and II enhances fibroblast attachment in vitro, Calcif. Tissue Int., 43, 50, 1988.
115.
Somerman, M.J., Prince, C.W., and Butler, W.T., Cell attachment activity of the 44-kilodalton bone phosphoprotein is not restricted to bone cells, Matrix, 9, 49, 1989.
116.
Mark, M.P., Butler, W.T., Prince, C.W., Finkelman, R.D., and Ruch, J.-V., Developmental expression of 44-kDa bone phosphoprotein (Osteopontin) and bone gamma-carboxyglutamic acid (Gla)-containing protein (osteocalcin) in calcifying tissues of rat, Differentiation, 37, 123, 1988.
117.
Franzén, A., Oldberg, A., and Solursh, M., Possible recruitment of osteoblastic precursor cells from hypertrophic chondrocytes during initial osteogenesis in cartilaginous limbs of young rats, Matrix, 9, 261, 1989.
118.
Yoon, K., Buenaga, R., and Rodan, G.A., Tissue specificity and developmental expression of rat osteopontin, Biochem. Biophys. Res. Commun., 148, 1129, 1987.
119.
Oldberg, A., Franzen, A., Heinegard, D., Pierrschbacker, M., and Ruoslahti, E., Identification of a bone sialoprotein (BSP) receptor in osteosarcoma cells, J. Biol. Chem., 263, 19, 433, 1988.
120.
Smith, J.W. and Cheresh, D.A., The Arg-Gly-Asp binding domain of the Vitronectin receptor, J. Biol. Chem., 263, 18726, 1988.
121.
Ruoslahti, E. and Pierrschbacher, M.D., New perspectives in cell adhesion: RGD and integrins, Science, 238, 491, 1987.
122.
Hynes, R. 0., Integrins: a family of cell surface receptors , Cell, 48, 549, 1987.
123.
Prince, C.W. and Butler, W.T., 1,25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells, Coll. Relat. Res., 7, 305, 1987.
124.
Noda, M., Yoon, K., Prince, C.W., Butler, W.T., and Rodan, G.A., Transcriptional regulation of Osteopontin production in rat osteosarcoma cells by type (3 transforming growth factor, J. Biol. Chem., 263, 13916, 1988.
125.
Noda, M. and Rodan, G.A., Transcriptional regulation of osteopontin production in rat osteoblast-like cells by parathyroid hormone, J. Cell Biol., 108, 713, 1989.
Oldberg, A., Franzen, A., and Heinegard, D., The primary structure of a cell binding bone sialoprotein, J. Biol. Chem., 263, 19430, 1988.
128.
Gorski, J.F. and Shimizu, K., Isolation of new phosphorylated glycoprotein from mineralized phase of bone that exhibits limited homology to adhesive protein osteopontin, J. Biol. Chem., 263, 15938, 1988.
129.
Gorski, J.P., Griffin, D., Dudley, G., Stanford, C., Thomas, R., Huang, C., Lai, E., Karr, B., and Solursh, M., Bone acidic glycoprotein-75 is a major synthetic product of osteoblastic cells, and, localized as 75 kDa and/or 50 kDa forms in mineralized phases of bone and growth plate and in serum, J. Biol. Chem., 265, 14956, 1990.
Tracy, R.P., Shull, S., Riggs, L.B., and Mann, K.G., The osteonectin family of proteins, Int. J. Biochem., 20, 653, 1988.
133.
Sage, H., Vernon, R.B., Funk, S.E., Everitt, E.A., and Angello, J., SPARC, a secreated protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca + 2-dependent binding to the extracellular matrix, J. Cell Biol., 109, 341, 1989.
134.
Nomura, S., Hashmi, S., McVey, J.H., Ham, J., Parker, M., and Hogan, B.L., Evidence for positive and negative regulatory elements in the 5%flanking sequence of the mouse SPARC (Osteonectin) gene, J. Biol. Chem., 264, 12202, 1989.
135.
Termine, J.D., Kleinman, H.D., Whitson, S.W., Conn, K.M., McGrarvey, M.L., and Martin, G.R., Osteonectin, a bone specific protein binding mineral to collagen, Cell, 26, 99, 1981.
136.
Termine, J.D., Belcourt, A.B., Conn, K.M., and Kleinman, H.K., Mineral and collagen binding proteins of fetal calf bone, J. Biochem., 256, 10403, 1981.
137.
Romberg, R.W., Werness, P.G., Lollar, P., Riggs, B.L., and Mann, K.G., Isolation and characterization of native adult Osteonectin, J. Biol. Chem., 260, 2728, 1985.
138.
Engel, J., Taylor, W., Paulsson, M., Sage, H., and Hogan, B., Calcium binding domains and calcium-induced conformational transition of SPARC/ BM-40/osteonectin, an extracellular glycoprotein expressed in mineralized and nonmineralized tissues, Biochemistry, 26, 6958, 1987.
139.
Doi, Y., Okuda, R., Takezawa, Y., Shibata, S., Moriwaki, Y., Wakamatsu, N., Shimizu, N., Moriyama, K., and Shimokawa, H., Osteonectin inhibiting de novo formation of apatite in the presence of collagen, Calcif. Tissue Int., 44, 200, 1989.
140.
Waddington, R.J., Embery, G., and Last, K.S., Glycosaminoglycans of human alveolar bone, Arch. Oral Biol., 34, 587, 1989.
141.
Fisher, L.W., The Chemistry and Biology of Mineralized Tissues, Butler, W. T., Ed., Alabama, 1985, 188.
142.
Heinegard, D., Bjorne-Persson, A., and Coster, L., The core proteins of large and small interstial proteoglycans from various connective tissues form distinct subgroups, Biochem. J., 230, 181, 1985.
143.
Johansson, S., Hedman, K., and Kjellen, L., Structure and interactions of proteoglycans in the extracellular matrix by cultured human fibroblasts, Biochem. J., 232, 161, 1985.
144.
Tenenbaum, H.C. and Hunter, G.K., Chondroitin sulfate inhibits calcification of bone formed in vitro, Bone Min., 2, 43, 1987.
145.
Wayner, E.A., Carter, W.G., Piotrowicz, R.S., and Kunicki, T.J., The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibits cell adhesion to fibronectin and react with platelet glycoprotein Ic-IIa, J. Cell Biol., 107, 1881, 1988.
Mosher, D. F., Ed., Fibronectin, Academic Press, New York, 1989.
148.
Hynes, R.O., Fibronectin: a family of complex and versatile glycoproteins derived from a single gene, Harvey Lect. Ser., 81, 113, 1987.
149.
Hynes, R. 0., Fibronectins, Sci. Am., 254, 42, 1986.
150.
Ruoslahti, E., Fibronectin and its receptors, Ann. Rev. Biochem., 57, 375, 1988.
151.
Hynes, R., Molecular biology of fibronectin, Ann. Rev. Cell Biol., 1, 67, 1985.
152.
Lawler, J., Weinstein, R., and Hynes, R. 0., Cell attachment to thrombospondin: the role of Arg-Gly-Asp, calcium and integrin receptors, J. Cell Biol., 107, 2351, 1988.
153.
Clezardin, P., Thrombospondin is synthesized and secreated by human osteoblasts and osteosarcoma cells: a model to study the different effects of thrombospondin in cell adhesion, Eur. J. Biochem., 181, 721, 1989.
154.
O'Shea, K.S. and Dixit, V.M., Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo, J. Cell Biol., 107, 2737, 1988.
155.
Hollenberg, M.D., Growth factors, their receptors and development, Am. J. Med. Genet., 34, 35, 1989.
156.
Canalis, E., Effect of platelet-derived growth factor on DNA and protein synthesis in cultured rat calvaria, Metabolism, 30, 970, 1981.
157.
Canalis, E., Centrella, M., and McCarthy, T.L., Effects of basic growth factor on bone formation in vitro, J. Clin. Invest., 81, 1572, 1988.
158.
Canalis, E., Lorenzo, J., and Burgess, W.H., Effects of endothelial growth factor on bone remodelling in vitro, J. Clin. Invest., 79, 52, 1987.
159.
Rodan, S.B., Wesolowski, G., and Thomas, K., Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor, Endocrinology, 121, 1917, 1987.
160.
McCarthy, T.L., Centrella, M., and Canalis, E., Regulatory effects of insulin-like growth factor I and II on bone collagen synthesis in rat calvarial cultures, Endocrinology, 124, 301, 1989.
161.
Centrella, M., Massague, J., and Canalis, E., Human platelet-derived transforming growth factor-β stimulates parameters of bone growth in fetal rat calvaria, Endocrinology, 119, 2306, 1986.
162.
Centrella, M., McCarthy, J., and Canalis, E., Transforming growth factor-β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone, J. Biol. Chem., 262, 2869, 1987.
163.
Bonewald, L.F. and Mundy, G.R., Role of transforming growth factor-beta in bone remodeling, Clin. Orthop. Rel. Res., 250, 261, 1990.
164.
Noda, M. and Rodan, G.A., Type β transforming growth factor (TGFβ) regulation of alkaline phosphatase expression and other phenotype-related mRNAs in osteoblast rat osteosarcoma cells, J. Cell Physiol., 133, 426, 1987.
165.
Guenther, H.L., Cecchini, M.G., Elford, P.R., and Fleisch, H., Effects of transforming growth factor type beta upon bone cell populations grown either in monolayer or semisolid medium, J. Bone Miner. Res., 3, 269, 1988.
166.
Centrella, M. and Canalis, E., Transforming and nontransforming growth factors are present in medium conditioned by fetal rat calvariae, Proc. Natl. Acad. Sci. U.S.A., 82, 7335, 1985.
167.
Chenu, C., Pfeilschifter, J., and Mundy, G.R., Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures, Proc. Natl. Acad. Sci. U.S.A., 85, 5683, 1988.
168.
Robey, P.G., Young, M.F., Flanders, K.C., Roche, N.S., Kondaiah, P., Reddi, A.H., Termine, J.D., Sporn, M.B., and Roberts, A.B., Osteoblasts synthesize and respond to transforming growth factor-type β (TGF-β) in vitro, J. Cell Biol., 105, 457, 1987.
169.
Rodan, G.A. and Martin, T.J., Role of osteoblasts in hormonal control of bone resorption-a hypothesis, Calcif. Tissue Int., 33, 349, 1981.
170.
Tashjian, A.H., Voelkel, E.F., Lazzaro, M., Singer, F.R., Roberts, A.B., Derynck, R., Winkler, M.E., and Levine, L., a and β transforming growth factors stimulate prosthaglandin production and bone resorption in cultured mouse calvaria, Proc. Natl. Acad. Sci. U.S.A., 82, 4535, 1985.
171.
Heino, J., Ignotz, R., Hemler, M., Crouse, C., and Massague, J., Regulation of cell adhesion receptors by transforming growth factor-β: concomitant regulation of integrins that share a common β1 subunit, J. Biol. Chem., 264, 380, 1989.
172.
Ignotz, R.A., Heino, J., and Massague, J., Regulation of cell adhesion receptors by transforming growth factor-p: regulation of vitronectin receptor and LFA-1, J. Biol. Chem., 264, 389, 1989.
173.
Banks, P., Grounding the gadabout growth factor, TGF-β, J. NIH Res., 1, 93, 1989.
174.
Reddi, A.H., Extracellular matrix and development, in Extracellular Matrix Biochemistry, Piez, K. A. and Reddi, A. H., Eds., Elsevier, New York, 1984, 375.
175.
Wozney, J.M., Celeste, A.J., and Mitsok, L.M., Novel regulations of bone formation: molecular clones and activities, Science, 242, 1528, 1988.
176.
Luyten, F.P., Cunningham, N.S., Ma, S., Muthukumaran, N., Hammonds, R.G., Vevins, W.B., Wood, W.I., and Reddi, A.H., Purification and partial amino acid sequence of Osteogenin, a protein initiating bone differentiation, J. Biol. Chem., 264, 13377, 1989.
177.
Reddi, A.H. and Anderson, W.A., Collagenous bone matrix-induced endochondral ossification and hemopoiesis, J. Cell Biol., 69, 557, 1976.
178.
Muthukumaran, N., Ma., S., and Reddi, A.H., Dose-dependence of and threshold for optimal bone induction by collagenous bone matrix and osteogenin-enriched fraction, Collagen Rel. Res., 8, 433, 1988.
179.
Guterman, I.A., Boman, T.E., Wang, G.-J., and Balian, G., Bone induction in intramuscular implants by demineralized bone matrix: sequential changes of collagen synthesis, Collagen Rel. Res., 8, 419, 1988.
180.
Vukicevic, S., Luyten, F.P., and Reddi, A.H., Osteogenin inhibits proliferation and stimulates differentiation in mouse osteoblast-like cells (MC3T3-El), Biochem. Biophys. Res. Comm., 166, 750, 1990.
181.
Rifkin, D. and Moscatelli, D., Recent developments in the cell biology of basic fibroblast growth factor, J. Cell Biol., 109, 1, 1989.
